Sonmol (朔茂) is a Chinese health-technology and medical-device brand focused primarily on respiratory health, home healthcare, first-aid devices, and respiratory monitoring/rehabilitation. The brand states it was founded in 2014, with headquarters in Shanghai and a production base in Chongqing. It has expanded its products to international markets 1.

Note that “Sonmol” appears to be used across several related corporate and brand entities. Information regarding the company distinguishes between claims made by Sonmol itself and independently documented records where possible.

Sonmol describes itself as a provider of innovative household and health products. The company reports that its products are sold in the United States, Europe, Japan, Russia, South Korea and other markets.

Sonmol states that it was founded in 2014, initially positioning itself around innovative household and healthcare products. Over time, its portfolio has become increasingly concentrated around respiratory health and medical-device applications.

Its Chinese-language brand positioning is now centered on the concept of “health respiratory solutions” and the slogan “Let safety arrive one step earlier”. The current product portfolio presented on its Chinese site is organized into three major categories:

• Nasal care
• Anti-choking / emergency first aid
• Cardiopulmonary and respiratory rehabilitation

This represents a narrower and more specialized positioning than the company’s older description of itself as a general household-and-health-product company.

One important point when researching Sonmol is that “Sonmol” is a brand name rather than simply the name of one universally defined corporation.

A U.S. trademark record identifies Shanghai Sonmol Internet Technology Co., Ltd. as the applicant/owner of the SONMOL trademark. The trademark covers medical products including nasal irrigators, sputum aspirators, respiratory-training devices, peak-flow meters, spirometers and choking-rescue devices 2.

There is also evidence of a broader Sonmol Group structure. Sonmol’s own corporate material describes the group as providing medical-device manufacturing, OEM and ODM services.

An independent corporate disclosure comes from AptarGroup, which stated in its 2024 annual filing that it invested $5 million in April 2020 for a 30% equity interest in Healthcare, Inc., Shanghai Sonmol Internet Technology Co., Ltd. and its subsidiary Shanghai Sonmol Medical Equipment Co., Ltd. Aptar described Sonmol as a Chinese company providing consumer electric and connected devices for asthma control. This investment provides independent evidence that Sonmol attracted backing from an established international healthcare/medical-device company.

Sonmol’s current product portfolio is strongly oriented toward breathing and respiratory-related healthcare.

Nasal-care products

One of Sonmol’s most visible product categories is nasal irrigation. Products shown on its Chinese site include:

• Electric nasal irrigators
• Nebulizing/spray nasal irrigators
• Traditional nasal irrigation devices
• Nasal-cleaning consumables
• Saline/seawater nasal-cleaning solutions

The company positions these products for everyday nasal hygiene and respiratory care.

Anti-choking devices

Sonmol also develops anti-choking emergency devices designed to assist in clearing an airway obstruction through negative pressure. Its product lineup includes portable models such as:

• MFAC-08VS
• MFAC-08VC

The mechanism is based on creating negative pressure through a piston system after a mask is placed over the mouth and nose.

The Malaysian Medical Device Authority’s database lists Sonmol-branded Anti-Choking Devices MFAC-08VS and MFAC-08VC, with a registration validity period of October 24, 2025 to October 23, 2030. This indicates movement beyond ordinary consumer wellness products into formally regulated medical-device territory.

Respiratory rehabilitation

Another major category is respiratory muscle training. Sonmol markets:

• Mechanical respiratory muscle trainers
• Electronic respiratory muscle trainers
• Devices intended to improve respiratory-muscle strength and endurance

The company also describes an associated app ecosystem for respiratory-muscle training.

Respiratory monitoring

Sonmol’s portfolio includes devices intended to measure respiratory function, particularly:

• Peak-flow meters
• Portable lung-function measurement devices
• Spirometry-related products
• Connected respiratory-monitoring devices

Its U.S. trademark filing specifically lists peak-flow meters and spirometers among the goods associated with the SONMOL mark 3. Sonmol also describes connected applications for monitoring peak expiratory flow and FEV1, including the ability to record and export measurements.

Sonmol presents itself as an R&D-oriented medical-device company, rather than solely a consumer-product marketer. According to its corporate website, the group reports holding:

• 46 invention patents
• 78 utility-model patents
• 73 design patents

These figures are company-reported. The company’s technology strategy revolves around combining physical medical devices with digital monitoring and connected-health applications. For example, Sonmol describes applications including:

• ePEF — monitoring peak-flow measurements
• eRMT — respiratory muscle training
• Asthma Manager — intended to allow doctors to review patient-uploaded respiratory information

This gives Sonmol a positioning somewhere between a traditional medical-device manufacturer and a connected-health company.

Sonmol does not appear to operate exclusively as a consumer brand. Its corporate website explicitly promotes OEM and ODM manufacturing. The company says it can provide:

• Product development
• Customized medical devices
• Private-label manufacturing
• OEM nasal-care devices
• ODM peak-flow meters
• Manufacturing of anti-choking devices
• Distribution partnerships

This indicates that Sonmol is simultaneously a consumer-facing brand and a B2B medical-device manufacturer/technology partner. Its corporate material says its manufacturing facilities can handle large orders while supporting customized OEM/ODM projects.

Sonmol states that its manufacturing operations are certified under ISO 13485 and ISO 9001, and that its products comply with applicable U.S. FDA, China FDA and other international regulatory requirements.

However, this should not be interpreted to mean that every Sonmol product is FDA-approved or medically certified in every country. Medical-device regulation is generally product-specific and market-specific. For example, the Malaysian regulatory database independently confirms registration for specific Sonmol anti-choking devices, while other products may have different regulatory classifications.

When evaluating a particular Sonmol product, it is necessary to check the exact model number, intended use, registration number and regulatory jurisdiction rather than relying on the Sonmol brand name alone.

Sonmol says it exports to more than 20 countries, including:

• United States
• European countries
• Japan
• Russia
• South Korea

It also claims to have served more than 2 million customers worldwide. These figures come from Sonmol’s own corporate materials. The company therefore appears to have a significant international distribution strategy rather than being exclusively China-focused.

Sonmol’s positioning has evolved toward a theme of Respiratory health + home medical care + emergency safety. Rather than competing primarily as a conventional pharmaceutical company, Sonmol focuses on devices that allow people to monitor, maintain or support respiratory health outside hospitals.

Its three current Chinese product pillars illustrate this: Nasal care → Respiratory rehabilitation → Emergency airway care. This creates a brand identity centered on “breathing health” rather than a broad medical-device catalog.

Sonmol’s corporate material mentions Nascool as another brand associated with its distribution/manufacturing activities. The company specifically describes opportunities to distribute Sonmol and Nascool products 4. This suggests that Sonmol Group’s business extends beyond a single consumer-facing brand and includes a broader brand/product ecosystem.

In broad terms, Sonmol sits in a middle ground within the healthcare sector:

Despite the broad “medical” image of the brand, Sonmol’s documented portfolio is much more specifically focused on respiratory and home-care devices than on the entire medical-device market.

One notable piece of information about Sonmol is its relationship with AptarGroup. Aptar’s annual report states that it invested $5 million for a 30% interest in Sonmol in 2020. Aptar characterized Sonmol as a provider of consumer electric and connected devices for asthma control. This relationship potentially provided Sonmol with access to additional international medical-device expertise and commercialization resources. It also helps distinguish Sonmol from an ordinary marketplace brand, as there is documented institutional investment in the underlying company.

The SONMOL trademark has been used for medical-device products for several years. A U.S. trademark record identifies Shanghai Sonmol Internet Technology Co., Ltd. as the owner/applicant. The filing covers Class 10 medical products including:

• Nasal irrigators
• Sputum aspirators
• Respiratory exercise devices
• Respiratory muscle-training devices
• Peak-flow meters
• Spirometers
• Mucus extractors
• Artificial-respiration equipment
• Choking-rescue devices

The record also indicates an earlier SONMOL registration dating to 2018, showing that the brand has had a U.S. trademark presence for several years.

From the available information, Sonmol’s main strengths appear to be:

• Focused expertise in respiratory health
• Broad portfolio spanning prevention, monitoring, rehabilitation and emergency care
• Combination of consumer products and regulated medical devices
• OEM/ODM capabilities
• International distribution
• Connected-health/software development
• Patent portfolio claimed by the company
• Investment relationship with AptarGroup
• Presence in multiple national medical-device markets

There are reasons to evaluate individual Sonmol products carefully.

First, “Sonmol” covers a fairly broad product ecosystem, and not every product should automatically be considered equivalent in regulatory status or clinical evidence.

Second, several statistics—such as the 2-million-customer figure, patent totals and number of countries served—are self-reported by Sonmol.

Third, regulatory status differs by product and country. The Malaysian registration of specific anti-choking models demonstrates regulatory recognition of those particular products, but does not establish the regulatory status of every Sonmol product globally.

Sonmol (朔茂) is a Chinese health-technology and medical-device brand founded in 2014 and headquartered in Shanghai, with manufacturing operations in Chongqing. The company has developed from a broader household-health-products business into a more specialized respiratory-health and home-medical-device company, with products covering nasal irrigation, respiratory monitoring, respiratory-muscle training, lung-function measurement and anti-choking emergency devices. It operates both as a consumer brand and as an OEM/ODM manufacturer, claims international distribution in more than 20 countries, and has reported more than two million customers. Its corporate ecosystem includes Shanghai Sonmol Internet Technology Co., Ltd., and AptarGroup disclosed a 30% investment in Sonmol in 2020.

Bottom line

If you are trying to understand what Sonmol really is, the simplest description would be:

Sonmol is a China-based respiratory-health and medical-device company that combines its own consumer brand with medical-device R&D, manufacturing, connected-health technology, and OEM/ODM services.

Its strongest identifiable specialization is breathing and respiratory care, rather than general healthcare or pharmaceuticals.

1. Sonmolmed – sonmolmed
2. SONMOL Trademark Application of Shanghai Sonmol Internet Technology Co., Ltd. – Serial Number 98295585 :: Justia…
3. SONMOL – Shanghai Sonmol Internet Technology Co., Ltd. Trademark Registration
4. Business Cooperate – sonmolmed